marijuana stocks

Form 8-K for SURNA INC.


27-Feb-2015

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01. Regulation FD Disclosure.Beginning on February 27, 2015, management of Surna Inc. will deliver to certain investors the presentation attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information included in this current report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this current report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

 

Item 9.01. Financial Statements and Exhibits.(d) Exhibits.

Exhibit No.   Description of Exhibit

   99.1       Investor presentation to be delivered by management of Surna Inc.
              beginning on February 27, 2015.

 

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$VPCO Announces Exchange Offer For Units Issued In July 2015

Vapor Corp. Announces Exchange Offer For Units Issued In July 2015 Vapor…

ParcelPal Technology Inc. (PTNYF) Welcomes Ontario MP Ben Lobb to the Advisory Board of Directors

ParcelPal Welcomes Ontario MP Ben Lobb to the Advisory Board of Directors…

CLS Holdings USA, Inc. (CLSH) Reviews Record Breaking and Transformational 2021 and Releases 2022 Outlook

CLS Holdings USA, Inc. Reviews Record Breaking and Transformational 2021 and Releases…

$LXRP Bioavailability Testing to Commence on Patent-Pending Technology

Bioavailability Testing to Commence on Lexaria’s Patent-Pending Technology Lexaria Corp. (LXRP) (CSE:LXX)…